From a molecular pharmacy viewpoint , Relafen 750 (naproxen sodium) presents a unique case of non-copyrightal drug effect. Its capacity to suppress prostaglandin production – specifically, the cyclooxygenase proteins COX-1 and COX-2 – demonstrates its clinical application in alleviating inflammatory conditions. The consequence of this preferent… Read More